Bodisen Biotech (LSE:BODI) COGS-to-Revenue : 0.69 (As of Jun. 2013)

View and export this data going back to . Start your Free Trial

What is Bodisen Biotech COGS-to-Revenue?

Bodisen Biotech's Cost of Goods Sold for the three months ended in Jun. 2013 was £0.31 Mil. Its Revenue for the three months ended in Jun. 2013 was £0.44 Mil.

Bodisen Biotech's COGS to Revenue for the three months ended in Jun. 2013 was 0.69.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Bodisen Biotech's Gross Margin % for the three months ended in Jun. 2013 was 30.68%.

Bodisen Biotech COGS-to-Revenue Historical Data

The historical data trend for Bodisen Biotech's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bodisen Biotech COGS-to-Revenue Chart

Bodisen Biotech Annual Data

Trend

Dec03

Dec04

Dec05

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

COGS-to-Revenue

Get a 7-Day Free Trial

0.95

0.89

0.87

0.73

0.86

Bodisen Biotech Quarterly Data
	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Jun13
COGS-to-Revenue	Get a 7-Day Free Trial															0.70	0.80	0.94	0.87	0.69

Bodisen Biotech COGS-to-Revenue Calculation

Bodisen Biotech's COGS to Revenue for the fiscal year that ended in Dec. 2012 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	4.297	/	4.987
	=	0.86

Bodisen Biotech's COGS to Revenue for the quarter that ended in Jun. 2013 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0.305	/	0.44
	=	0.69

Bodisen Biotech (LSE:BODI) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Bodisen Biotech's Gross Margin % for the three months ended in Jun. 2013 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	0.305 / 0.44
	=	30.68 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Bodisen Biotech COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Bodisen Biotech's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.